Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo

Por Denicolaï, Emilie, Baeza-Kallee, Nathalie, Tchoghandjian, Aurélie, Carré, Manon, Colin, Carole, Jiglaire, Carine Jiguet, Mercurio, Sandy, Beclin, Christophe, Figarella-Branger, Dominique
Publicado no Oncotarget (2014)

Molecular heterogeneity of glioblastomas: does location matter?

Por Denicolaï, Emilie, Tabouret, Emeline, Colin, Carole, Metellus, Philippe, Nanni, Isabelle, Boucard, Celine, Tchoghandjian, Aurélie, Meyronet, David, Baeza-Kallee, Nathalie, Chinot, Olivier, Figarella-Branger, Dominique
Publicado no Oncotarget (2015)

AI-29 ANGIOGENIC SWITCH FROM VEGFR2/HIF1α IN NEWLY DIAGNOSED GLIOBLASTOMA (GB) TO CXCR4-SDF1 PATHWAY IN RECURRENT PAIRED TUMOR AFTER RADIOTHERAPY (RT)-TEMOZOLOMIDE (TMZ)

Por Tabouret, Emeline, Tchoghandjian, Aurelie, Denicolai, Emilie, Delfino, Christine, Metellus, Philippe, Padovani, Laetitia, Nanni, Isabelle, Barrie, Maryline, Boucard, Celine, Ouafik, L'Houcine, Figarella-Branger, Dominique, Chinot, Olivier
Publicado em 2014

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway

Por Tabouret, Emeline, Tchoghandjian, Aurelie, Denicolai, Emilie, Delfino, Christine, Metellus, Philippe, Graillon, Thomas, Boucard, Celine, Nanni, Isabelle, Padovani, Laetitia, Ouafik, L'Houcine, Figarella-Branger, Dominique, Chinot, Olivier
Publicado no Oncotarget (2015)